ArticleTrials2024

Quabodepistat in combination with delamanid and bedaquiline in participants with drug-susceptible pulmonary tuberculosis: protocol for a multicenter, phase 2b/c, open-label, randomized, dose-finding trial to evaluate safety and efficacy.

Rodney Dawson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.